Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 263

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer

Open access
Groner, Anna C., Cato, Laura, de Tribolet-Hardy, Jonas, Bernasocchi, Tiziano, Janouskova, Hana, Melchers, Diana, Houtman, René, Cato, Andrew C.B., Tschopp, Patrick, Gu, Lei, Corsinotti, Andrea, Zhong, Qing, Fankhauser, Christian, Fritz, Christine, Poyet, Cédric, Wagner, Ulrich, Guo, Tiannan, Aebersold, Ruedi, Garraway, Levi A., Wild, Peter J., Theurillat, Jean-Philippe, Brown, Myles·2016·Cancer Cell

Abstract

Summary Androgen receptor (AR) signaling is a key driver of prostate cancer (PC). While androgen-deprivation therapy is transiently effective in advanced disease, tumors often progress to a lethal castration-resistant state (CRPC). We show that recurrent PC-driver mutations in SPOP stabilize the TRIM24 protein, which promotes proliferation under low androgen conditions. TRIM24 augments AR signaling, and AR and TRIM24 co-activated genes are significantly up-regulated in CRPC. Expression of TRIM24 protein increases from primary PC to CRPC, and both TRIM24 protein levels and the AR/TRIM24 gene signature predict disease-recurrence. Analyses in CRPC cells reveal that the TRIM24 bromodomain and the AR-interacting motif are essential to support proliferation. These data provide a rationale for therapeutic TRIM24 targeting in SPOP-mutant and CRPC patients.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ccell.2016.04.012

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 263

Metadata

Authors
Groner, A. C., Cato, L., de Tribolet-Hardy, J., Bernasocchi, T., Janouskova, H., Melchers, D., Houtman, R., Cato, A. C. B., Tschopp, P., Gu, L., Corsinotti, A., Zhong, Q., Fankhauser, C., Fritz, C., Poyet, C., Wagner, U., Guo, T., Aebersold, R., Garraway, L. A., Wild, P. J., Theurillat, J.-P., & Brown, M.
Venue
Cancer Cell
Publisher
Elsevier BV
Published
2016-06
Volume
29
Issue
6
Pages
846-858
ISSN
1535-6108 (ISSN-L)
OpenAlex
W2406478006
Cited by
263
References
54
FWCI
21.45
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer. https://app.cochat.ai/papers/10.1016/j.ccell.2016.04.012
The paper
Groner, A. C., Cato, L., de Tribolet-Hardy, J., Bernasocchi, T., Janouskova, H., Melchers, D., Houtman, R., Cato, A. C. B., Tschopp, P., Gu, L., Corsinotti, A., Zhong, Q., Fankhauser, C., Fritz, C., Poyet, C., Wagner, U., Guo, T., Aebersold, R., Garraway, L. A., . . . Brown, M. (2016). TRIM24 Is an Oncogenic Transcriptional Activator in Prostate Cancer. Cancer Cell. https://doi.org/10.1016/j.ccell.2016.04.012

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.